勘误：跨膜和卷曲螺旋结构域3是预测肝细胞癌免疫检查点阻断疗效的诊断生物标志物。
Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma.
作者信息
Hu Xinyao, Zhu Hua, Feng Shi, Wang Chaoqun, Ye Yingze, Xiong Xiaoxing
机构信息
Cancer Center, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.
Department of Neurosurgery, The Affiliated Huzhou Hospital, Zhejiang University School of Medicine (Huzhou Central Hospital), Huzhou, China.
出版信息
Front Genet. 2023 Jan 16;13:1117731. doi: 10.3389/fgene.2022.1117731. eCollection 2022.
Abstract
[This corrects the article DOI: 10.3389/fgene.2022.1006357.].
摘要
[本文更正了文章的数字对象标识符：10.3389/fgene.2022.1006357。]
相似文献
1
Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma.勘误：跨膜和卷曲螺旋结构域3是预测肝细胞癌免疫检查点阻断疗效的诊断生物标志物。
Front Genet. 2023 Jan 16;13:1117731. doi: 10.3389/fgene.2022.1117731. eCollection 2022.
2
Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma.跨膜和卷曲螺旋结构域3是预测肝细胞癌免疫检查点阻断疗效的诊断生物标志物。
Front Genet. 2022 Sep 29;13:1006357. doi: 10.3389/fgene.2022.1006357. eCollection 2022.
3
Corrigendum: CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis.勘误：CCDC25可能是肝细胞癌的潜在诊断和预后标志物：来自微阵列分析的结果。
Front Surg. 2023 Mar 28;10:1175721. doi: 10.3389/fsurg.2023.1175721. eCollection 2023.
4
Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma.KIFC1在肝细胞癌中的预后价值及免疫作用
Front Mol Biosci. 2022 Jan 17;8:799651. doi: 10.3389/fmolb.2021.799651. eCollection 2021.
5
Can Combined Therapy Benefit Immune Checkpoint Blockade Response in Hepatocellular Carcinoma?联合治疗能否改善肝癌的免疫检查点阻断反应？
Anticancer Agents Med Chem. 2019;19(2):222-228. doi: 10.2174/1871520618666181114112431.
6
Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma.勘误：开发一种用于预测胶质瘤患者生存率及对免疫检查点抑制剂反应的免疫相关特征。
Front Genet. 2022 Aug 17;13:961153. doi: 10.3389/fgene.2022.961153. eCollection 2022.
7
Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma.丝氨酸蛋白酶抑制剂 Kazal 型 1，一种潜在的生物标志物，用于早期检测、靶向和预测肝细胞癌对免疫检查点阻断治疗的反应。
Front Immunol. 2022 Jul 18;13:923031. doi: 10.3389/fimmu.2022.923031. eCollection 2022.
8
Corrigendum: Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma.勘误：鉴定用于预测乳头状肾细胞癌生存及免疫治疗疗效的免疫相关基因预后指数。
Front Genet. 2024 Jun 26;15:1440802. doi: 10.3389/fgene.2024.1440802. eCollection 2024.
9
Non-coding ribonucleic acid-mediated upregulation leads to poor prognosis with suppressed immune infiltration in liver hepatocellular carcinoma.非编码核糖核酸介导的上调导致肝细胞癌预后不良并伴有免疫浸润受抑制。
Front Genet. 2022 Sep 21;13:916847. doi: 10.3389/fgene.2022.916847. eCollection 2022.
10
CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.CPNE1是一种潜在的预后生物标志物，与免疫浸润相关，并促进肝细胞癌的进展。
Cancer Cell Int. 2022 Feb 9;22(1):67. doi: 10.1186/s12935-022-02485-2.
引用本文的文献
1
Pre-diagnosis blood DNA methylation profiling of twin pairs discordant for breast cancer points to the importance of environmental risk factors.双胞胎乳腺癌发病不一致的预诊断血 DNA 甲基化分析表明环境风险因素的重要性。
Clin Epigenetics. 2024 Nov 18;16(1):160. doi: 10.1186/s13148-024-01767-y.
Zotero 插件